Greenfern Industries Limited
GFI.NZ
New Zealand Exchange0.02
NZD
- -
- -
Greenfern Industries Limited
GFI.NZ
(New Zealand Exchange)
Recent
price
0.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Greenfern Industries Limited operates as a medicinal cannabis research, biotechnology, and wellness company based in Auckland, New Zealand. Founded in 2018, the company focuses on producing licensed medicinal cannabis products, industrial hemp, hemp food, and hemp-based body care products. Its core product portfolio includes medicinal cannabis flower cultivation and processing; hemp-based health and beauty products, including the MaTō body care line; and hemp seed, hemp seed oil, and hemp cake sold as ingredients for fast-moving consumer goods. Greenfern has developed and expanded cultivation facilities with Good Agricultural and Collection Practices (GACP) certification, enabling multiple harvests per year with a forecasted annual output of 350-450 kilograms. Recently, Greenfern Industries has faced significant operational challenges, including going into receivership in early 2025 following financial difficulties and leadership resignations. The company appointed Waterstone Insolvency as receivers, with assets including a hydroelectric power station adjacent to its indoor growing and processing facilities in Normanby, Taranaki, likely to be sold. Strategic setbacks included the administration of an Australian manufacturing partner and the winding down of its Australian partnership with Cannvalate, impacting its expansion efforts in Australia. Despite these issues, Greenfern had begun generating revenue from medicinal cannabis flower production and was recognized as New Zealand’s first Toitū carbonzero certified medicinal cannabis and industrial hemp company. The company continues to focus on medicinal cannabis flower production and hemp product sales domestically, with previous ambitions for international market expansion. Greenfern Industries targets healthcare, wellness, and fast-moving consumer goods sectors primarily in New Zealand, with prior strategic efforts aimed at expanding into Australia and the European Union. The company leverages its proprietary cultivation and processing facilities and holds a notable position as an early-stage licensed medicinal cannabis and hemp producer in New Zealand. Its business model includes both wholesale distribution and retail sales of its products while maintaining research and development activities in medicinal cannabis biotechnology. The company’s headquarters is in Auckland, New Zealand. Overall, Greenfern Industries Limited offers licensed medicinal cannabis and industrial hemp-based therapeutic, wellness, and consumer products with a focus on cultivation, processing, and distribution. Its recent significant changes involve receivership proceedings, asset liquidation plans, leadership transition, and strategic withdrawal from certain Australian market partnerships, reflecting substantial operational and financial restructuring within the last two years. This description captures Greenfern Industries Limited’s business operations, product offerings, and latest major changes as of late 2025.